SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
GenMark Diagnostics, Inc.
(Exact name of registrant as specified in its charter)
|(State of incorporation or organization)||(I.R.S. Employer Identification No.)|
|757 S. Raymond Avenue|
|(Address of principal executive offices)||(Zip Code)|
|Securities to be registered pursuant to Section 12(b) of the Act:|
|Common stock, par value $0.0001 per share||The NASDAQ Stock Market LLC|
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. þ
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨
Securities Act registration statement file number to which this form relates: 333-165562.
Securities to be registered pursuant to Section 12(g) of the Act: None.
Item 1. Description of Registrants Securities to be Registered
GenMark Diagnostics, Inc. (the Registrant) registers hereunder its common stock, $0.0001 par value per share (the Common Stock). A description of the Registrants Common Stock is incorporated herein by reference to the section captioned Description of Capital Stock in the Registrants Registration Statement on Form S-1 (File No. 333-165562) as originally filed with the Securities and Exchange Commission (the Commission) on March 19, 2010, as amended (the Registration Statement), and in the prospectus included in the Registration Statement to be filed separately by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which prospectus shall be deemed to be incorporated by reference herein.
Item 2. Exhibits
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
|Date: May 24, 2010||GenMark Diagnostics, Inc.|
|By:||/S/ STEVEN KEMPER|
|Chief Financial Officer|